Goldman Sachs: Biogen Inc. (BIIB) Is A Top Growth Investor Stock
We recently made a list of Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest Investment For Growth. In this ...
Biogen price target lowered to $207 from $251 at Mizuho
Mizuho lowered the firm’s price target on Biogen (BIIB) to $207 from $251 and keeps an Outperform rating on the shares. The analyst updated ...
Petri Dish: Kronos Bio seeks merger; Former Biogen R&D head joins investment firm
Happenings in Boston’s life sciences ecosystem this past week include the departure of a general partner from Apple Tree Partners for another firm, Kronos Bio seeks "strategic alternatives" and new ...
Biogen Inc. (BIIB): Among the Best Genomics Stocks to Buy Right Now
We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at ...